期刊
CURRENT OPINION IN CARDIOLOGY
卷 15, 期 6, 页码 416-421出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00001573-200011000-00008
关键词
-
To an increasing degree, cardiology and endocrinology are finding a broadening interface. There is little doubt that atherosclerosis is in many ways a metabolic disorder, just as it is becoming increasingly clear that diabetes is a vascular disease, Framing such notions is evidence of diabetes as a risk equivalent for coronary disease, and clinical cardiovascular trials demonstrate the impact of altering lipid metabolism. Although the focus has been on statins and LDL, data continues to emerge for other therapies for triglycerides and HDL, These issues are discussed, as are future directions for metabolic therapeutic interventions for Vascular disease. (C) 2000 Lippincott Williams & Wilkins, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据